Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Percutaneous Neurostimulation in Knee Osteoarthritis

NCT: NCT07637682 · RECRUITING

NCT IDNCT07637682
StatusRECRUITING
Start Date2026-06-02
Completion2026-11
SponsorTanta University (OTHER)
First posted
Last updated

Brief Summary

Peripheral nerve stimulation (PNS) is a drug-free pain management procedure that uses electrical impulses to target specific nerves and block pain signals. PNS helps decrease perception of pain, providing real answers to patients dealing with chronic knee pain. The case study discussed in this presentation is of the use of PNS targeting the superior lateral genicular nerve and the saphenous nerve for a patient with moderate to severe knee pain from osteoarthritis

Frequently Asked Questions

What is Percutaneous Neurostimulation in Knee Osteoarthritis?

Percutaneous Neurostimulation in Knee Osteoarthritis is a clinical trial registered under NCT07637682. Current status: RECRUITING.

What is the status of NCT07637682?

The current status of NCT07637682 (Percutaneous Neurostimulation in Knee Osteoarthritis) is: RECRUITING.

When did Percutaneous Neurostimulation in Knee Osteoarthritis start?

Percutaneous Neurostimulation in Knee Osteoarthritis started on 2026-06-02.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.